Abstract
AbstractAlzheimer’s Disease (AD) is a neurodegenerative disorder that is still not fully understood. Sex modifies AD vulnerability, but the reasons for this are largely unknown. We utilize two independent electronic medical record (EMR) systems across 44,288 patients to perform deep clinical phenotyping and network analysis to gain insight into clinical characteristics and sex-specific clinical associations in AD. Embeddings and network representation of patient diagnoses demonstrate greater comorbidity interactions in AD in comparison to matched controls. Enrichment analysis identifies multiple known and new diagnostic, medication, and lab result associations across the whole cohort and in a sex-stratified analysis. With this data-driven method of phenotyping, we can represent AD complexity and generate hypotheses of clinical factors that can be followed-up for further diagnostic and predictive analyses, mechanistic understanding, or drug repurposing and therapeutic approaches.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference125 articles.
1. Alzheimer’s Association. 2020 Alzheimer’s disease facts and figures. Alzheimers Dement. 16, 391–460 (2020).
2. Ferreira, D., Wahlund, L.-O. & Westman, E. The heterogeneity within Alzheimer’s disease. Aging 10, 3058–3060 (2018).
3. Neu, S. C. et al. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis. JAMA Neurol. 74, 1178 (2017).
4. Cognitive Function and Ageing Studies (CFAS) Collaboration et al. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat. Commun. 7, 11398 (2016).
5. Dubal, D. B. in Handbook of Clinical Neurology Vol. 175 (eds Lanzenberger, R., Kranz, G. S. & Savic, I.) Ch.16, 261–273 (Elsevier, 2020).